Thromb Haemost 1979; 42(03): 864-872
DOI: 10.1055/s-0038-1666935
Original Article
Schattauer GmbH Stuttgart

Crosslinking of Monomeric Fibrin by Factor XIIIa

Beatriz N Dardik
The Research Division, the Cleveland Clinic Foundation, Cleveland, OH 44106, U.S.A.
,
John R Shainoff
The Research Division, the Cleveland Clinic Foundation, Cleveland, OH 44106, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 23 September 1978

Accepted 30 December 1978

Publication Date:
23 August 2018 (online)

Summary

The acceleration of crosslinking that accompanies transformation of fibrinogen to fibrin has been suggested to arise from the aggregation of the fibrinogen rather than a change in affinity for the crosslinking enzyme, factor Xllla. A test of the importance of aggregation has been obtained from studies on the effect of removing fibrinopeptide B from fibrinogen. Specific removal of fibrinopeptide B through reaction of human fibrinogen with copperhead venom procoagulant enzyme at low temperatures yields fibrin which dissolves on warming to 37° C and dissociates fully into monomers on dilution to a concentration below 0.2 mg/ml. When this fibrin and a fibrin lacking both fibrinopeptides A and B were compared at high concentrations above 2 mg/ml which favored a high degree of aggregation of both forms, they underwent crosslinking at similar rates that were approximately thirty two (25 ± 0.5) times faster than crosslinking of fibrinogen. However, at concentrations below 0.2 mg/ml, the fibrin lacking B alone underwent crosslinking at only one sixty-fourth of the rate of fibrin lacking both fibrinopeptides A and B. The relatively slow crosslinking in dilute solutions of the fibrin lacking fibrinopeptide B appeared due to the unique dissociation of this fibrin into monomers at low concentrations. As judged from both the rate of stable clot formation and the rate of formation of dimeric y-chains, crosslinking of the monomers did not differ from that of fibrinogen.

 
  • References

  • 1 Blombäck B, Blombäck M. 1956; Purification of human and bovine fibrinogen. Arkiv för Kemi 10: 415
  • 2 Doolittle RF, Chen R, Lau F. 1971; Hybrid fibrin: Proof of the intermolecular nature of γ-γ crosshnking units. Biochemical and Biophysical Research Communications 44: 94
  • 3 Doolittle RF. 1973; Structural details of fibrin stabilization: Implications for fibrinogen structure and initial fibrin formation. Thrombosis et Diathesis Haemorrhagica Suppl (Suppl. 54) 155
  • 4 FinlaysoN JS, Mosesson MW. 1963; Heterogeneity of human fibrinogen. Biochemistry 2: 42
  • 5 Furlan M, Seelich T, Beck EA. 1976; Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B. Thrombosis and Haemostasis 36: 582
  • 6 Herzig RH, Ratnoff OD, Shainoff JR. 1970; Studies on a procoagulant fraction of Southern copperhead snake venom: The preferential release of fibrinopeptide B. The Journal of Laboratory and Clinical Medicine 76 (03) 451
  • 7 Hudry-Clergeon G, Marguerie G, Pouit L, Suscillon M. 1975; Models proposed for the fibrinogen molecule and for the polymerization process. Thrombosis Research 6: 533
  • 8 Kanaide H, Shainoff JR. 1975; Cross-linking of fibrinogen and fibrin by fibrin-stabilizing factor (factor XIIIa). The Journal of Laboratory and Clinical Medicine 85 (04) 574
  • 9 Loewy AG, Dunathan K, Kriel R, Wolfinger H jr L. 1961; Fibrinase I. Purification of substrate and enzyme. Journal of Biological Chemistry 236: 2625
  • 10 Lorand L, Ong HH. 1966; Labeling of amine-acceptor cross-linking sites of fibrin by transpeptidation. Biochemistry 5: 1747
  • 11 Lorand L, Gotoh T. 1970. Fibrinoligase. The fibrin stabilizing factor system. In Perlmann GE, Lorand L. eds Methods in Enzymology Vol. XIX Proteolytic Enzymes. Academic Press; New York: p 770
  • 12 Lorand L. 1970; Physiological crosslinking of fibrin. Thrombosis et Diathesis Haemorrhagica Suppl 39: 75
  • 13 Pizzo SV, Schwartz ML, Hill RL, Mckee PA. 1972; The effect of plasmin on the subunit structure of human fibrinogen. The Journal of Biological Chemistry 247 (03) 636
  • 14 Prentice CR M, Ratnoff OD, Breckenridge RT. 1967; Experiments on the nature of the prothrombin-converting principle: Alteration of proaccelerin by thrombin. British Journal of Haematology 13: 898
  • 15 Seelich T, Furlan M, Beck EA. 1976; Reactivity of fibrinogen crosslinking sites in the absence of thrombin. Thrombosis and Haemostasis 35: 620
  • 16 Shainoff JR, Page IH. 1962; Significance of cryoprofibrin in fibrinogen-fibrin conversion. Journal of Experimental Medicine 116: 687
  • 17 Shainoff JR, Lahiri B, Bumpus FM. 1970; Ultracentrifuge studies on the reaction between thrombin and plasminized fibrinogen. Thrombosis et Diathesis Haemorrhagica Suppl (Suppl. 39) 203
  • 18 Shainoff JR, Dardik BN. 1977; Firbinopeptide B and aggregation of fibrinogen - VIth International Congress on Thrombosis and Haemostasis. 38 (01) 191
  • 19 Shainoff JR, Dardik BN. 1979; Fibrinopeptide B and aggregation of fibrinogen. Science 204: 200
  • 20 Shen LL, Hermans J, McDonagh J, McDonagh RP. 1977; Role of fibrinopeptide B release: comparison of fibrins produced by thrombin and Ancrod. American Journal of Physiology 232 (06) H 629
  • 21 Stewart GT, Niewiarowsky S. 1969; Nonenzymatic polymerization of fibrinogen by protamine sulfate. An electron microscope study Biochimica et Biophysica Acta 194: 462